Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.4450
+0.0450 (1.88%)
NASDAQ· Last Trade: Aug 19th, 2:12 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors